Establishment Labs® (NASDAQ:ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing, and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform.
Motiva Implants® are produced at two FDA-compliant state-of-the-art facilities in Costa Rica and are currently approved for commercial distribution in over 70 countries through exclusive distributors or a direct salesforce.
In March 2018, Establishment Labs® received approval for an investigational device exemption (IDE) from the FDA to initiate the Motiva Implants® clinical trial in the United States.
|
|
|
501-1,000 employees
View all Establishment Labs employees
|
|
Medical Devices
|
|
Coyol Free Zone, Bldg 25, Coyol , Alajuela 20102, CR
|
|
None
|
Juan Jose Chacon Quiros is the CEO of Establishment Labs. To contact Juan Jose Chacon Quiros email at [email protected].
The decision makers in Establishment Labs are Alejandro Hueda, Anne Pugh, Daniel Jimenez, etc. Click to Find Establishment Labs decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.